Researcher
Ewout Landeloos
- Disciplines (Flanders Institute for Biotechnology):Analysis of next-generation sequence data, Cell death, Cancer biology
- Disciplines (KU Leuven):Oncology
Affiliations
- Department of Oncology (Department)
Member
From22 Aug 2022 → Today - Laboratory for Molecular Cancer Biology (VIB-KU Leuven) (Division)
Member
From6 Aug 2018 → 5 Aug 2022 - Marine Lab (Research group)
Member
From6 Aug 2018 → 5 Aug 2022
Publications
1 - 10 of 10
- A TCF4-dependent gene regulatory network confers resistance to immunotherapy in melanoma(2024)
Authors: Dennis Pedri, Ewout Landeloos, Yannick Van Herck, Katy Vandereyken, Thierry Voet, Wim Annaert, Diether Lambrechts, Veerle Boecxstaens, Joost van den Oord, Francesca Bosisio, et al.
- SERPINB9 is commonly amplified and high expression in cancer cells correlates with poor immune checkpoint blockade response(2022)
Authors: Ewout Landeloos, Yannick Van Herck, Oliver Bechter, Chris Marine
- A cellular hierarchy in melanoma uncouples growth and metastasis (vol 610, pg 190, 2022)(2022)
Authors: Panagiotis Karras, Joanna Poźniak, Nina Van Raemdonck, Ewout Landeloos, Yannick Van Herck, Michael Dewaele, Yichao Hua, Gabriele Bergers, Francesca Bosisio, Joost van den Oord, et al.
Pages: E4 - E4 - A cellular hierarchy in melanoma uncouples growth and metastasis(2022)
Authors: Panagiotis Karras, Ada Nowosad, Nina Van Raemdonck, Ewout Landeloos, Yannick Van Herck, Dennis Pedri, Michael Dewaele, Yichao Hua, Gabriele Bergers, Francesca Bosisio, et al.
Pages: 190 - + - Epithelial-to-mesenchymal-like transition events in melanoma(2022)
Authors: Dennis Pedri, Panagiotis Karras, Ewout Landeloos, Chris Marine
Pages: 1352 - 1368 - Plexin-A4 Mediates Cytotoxic T-cell Trafficking and Exclusion in Cancer(2022)
Authors: Ward Celus, Silvia Rivis, Ewout Landeloos, Yannick Van Herck, Abhishek Garg, Chris Marine, Mario di Matteo, Oliver Bechter, Max Mazzone
Pages: 126 - 141 - itraconazole for COVID-19: Preclinical studies and a proof-of-concept randomized clinical trial Laurens (vol 66, 103288, 2021)(2021)
Authors: Laurens Liesenborghs, Dirk Jochmans, Ann Belmans, Iwein Gyselinck, Sebastiaan ter Horst, Erwin Dreesen, Tatjana Geukens, Ewout Landeloos, Bert Vandenberk, Lorenz Van der Linden, et al.
- Itraconazole for COVID-19: preclinical studies and a proof-of-concept randomized clinical trial(2021)
Authors: Laurens Liesenborghs, Dirk Jochmans, Ann Belmans, Iwein Gyselinck, Laure-Anne Teuwen, Sebastiaan ter Horst, Erwin Dreesen, Tatjana Geukens, Ewout Landeloos, Vincent Geldhof, et al.
- Direct antivirals working against the novel coronavirus: azithromycin (DAWn-AZITHRO), a randomized, multicenter, open-label, adaptive, proof-of-concept clinical trial of new antivirals working against SARS-CoV-2-azithromycin (vol 22, 126, 2021)(2021)
Authors: Iwein Gyselinck, Laurens Liesenborghs, Ewout Landeloos, Ann Belmans, Geert Verbeke, Peter Verhamme, Robin Vos, Wim Janssens
Pages: 0 - 0 - Direct antivirals working against the novel coronavirus: azithromycin (DAWn-AZITHRO), a randomized, multicenter, open-label, adaptive, proof-of-concept clinical trial of new antivirals working against SARS-CoV-2-azithromycin trial(2021)
Authors: Iwein Gyselinck, Ewout Landeloos, Ann Belmans, Geert Verbeke, Peter Verhamme, Robin Vos, Wim Janssens